STAT+: Definium LSD therapy helped patients with major depression in late-stage trial

STAT News

STAT+: Definium LSD therapy helped patients with major depression in late-stage trial

이 뉴스, 어떠셨어요?

한 번의 탭으로 반응을 남겨요 · 로그인 불필요

Definium Therapeutics said that its LSD therapy helped patients with major depression in its first Phase 3 trial, bringing the psychedelic drug closer to a potential approval. ...

전문 보기

STAT+: Definium LSD therapy helped patients with major depression in late-stage trial

이 뉴스, 어떠셨어요?

관련 뉴스

'science' 카테고리 뉴스

STAT+: FDA to launch pilot program to speed up early-stage clinical trials

Engineers test, validate novel method to improve pharmaceutical research and development

Two patients with severe autoimmune disease remain relapse-free for over 15 years after stem cell transplant

STAT의 다른 기사

Confirmed Ebola cases in Congo outbreak top 1,000 with 254 deaths, authorities say

STAT+: Another big deal, another sign biotech M&A is back

STAT+: Despite transplant referrals, most kidney patients don’t make the waitlist